Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Classical hematology 1CNS 1

Conditions

Prostatic Neoplasms 739Carcinoma, Renal Cell 234Urinary Bladder Neoplasms 212Carcinoma, Transitional Cell 115Breast Neoplasms 101Kidney Neoplasms 96Neoplasms 88Carcinoma, Non-Small-Cell Lung 83Ovarian Neoplasms 81Melanoma 79Colorectal Neoplasms 73Neoplasm Metastasis 69Lung Neoplasms 59Non-Muscle Invasive Bladder Neoplasms 55Pancreatic Neoplasms 49Sarcoma 45Endometrial Neoplasms 45Stomach Neoplasms 40Uterine Cervical Neoplasms 39Carcinoma, Hepatocellular 34Adenocarcinoma 34Wilms Tumor 32Esophageal Neoplasms 31Triple Negative Breast Neoplasms 30Squamous Cell Carcinoma of Head and Neck 29Head and Neck Neoplasms 28Testicular Neoplasms 25Metastatic Castration-resistant Prostate Cancer 25Disease 24Colonic Neoplasms 24

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Huntington Disease × Genitourinary × 90 days × Clear all
NCT06147414 2026-04-23

DANNIgene

Assistance Publique - Hôpitaux de Paris

Recruiting
550 enrolled
CNSClassical hematologyGenitourinary

Hydrocephalus, X-linked, Neurofibromatosis-Noonan syndrome, Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Fragile X Syndrome, Hemophilia A, Huntington Disease, Myotonic Dystrophy, Polycystic Kidney, Autosomal Recessive, Neurofibromatoses, Muscular Dystrophy, Duchenne

Data powered by HemOnc (CC BY 4.0) Colophon âš¡